HEALTH CARE ROUNDUP
• Merck Says Appeals Court Overturns Verdict in Vioxx Case
• Study Likely Spells End For Anti-Bleeding Drug
• Families Will Make Case For Vaccine Link to Autism
• Group Asks Government to End Use of Birth-Control Patch
• Dennis Quaid Testifies of Peril to Newborn Twins
• EPA Testing Air After Twister in Toxic Okla. Town
• Minn. Gov Signs Bill to Pay Bridge Collapse Victims
FDA ACTIONS
• Doctors Told To Check Up On Heart Device Patients
• China Accuses U.S. Of Shoddy Probe Into Tainted Heparin
RECENT CASE SUMMARIES
• North Texas Specialty Physicians v. FTC
• Acumed, LLC v. Stryker Corp.
• B & H Med., L.L.C. v. ABP Admin., Inc.
You May FREELY Redistribute This E-Mail in Whole
HEALTH CARE ROUNDUP:
MERCK SAYS APPEALS COURT OVERTURNS VERDICT IN VIOXX CASE
(Associated Press) - A Texas appeals court on Wednesday overturned a multimillion-dollar verdict against Merck & Co. in a case involving its withdrawn painkiller Vioxx. Read more...
Related Resources
• Read the Opinion (Merck v. Garza)
• Vioxx Legal Claims: Your Rights
STUDY LIKELY SPELLS END FOR ANTI-BLEEDING DRUG
(Associated Press) - An anti-bleeding drug probably will stay off the market, experts say, after a rigorous study found patients getting the medication during heart surgery were much more likely to die than patients given other drugs. Read more...
FAMILIES WILL MAKE CASE FOR VACCINE LINK TO AUTISM
(Associated Press) - The Institute of Medicine said in 2004 there was no credible evidence to show that vaccines containing the preservative thimerosal led to autism in children. But thousands of families have a different take based on personal experience. Read more...
GROUP ASKS GOVERNMENT TO END USE OF BIRTH-CONTROL PATCH
(Associated Press) - A consumer advocacy group petitioned the government [last week] to pull the birth-control patch off the market, calling it far riskier than the pill. Read more...
DENNIS QUAID TESTIFIES OF PERIL TO NEWBORN TWINS
(Associated Press) - Actor Dennis Quaid told Congress on Wednesday of a harrowing, near-fatal drug mixup in which his newborn twins were administered 1,000 times the normal dose of a blood thinner. Read more...
Related Resources
• Medical Malpractice
EPA TESTING AIR AFTER TWISTER IN TOXIC OKLA. TOWN
(Associated Press) - The Environmental Protection Agency was preparing to conduct air and soil tests to check for high lead levels Monday after a deadly tornado blew through Picher, a town so polluted with lead-filled mining waste that it's a Superfund site. Read more...
MINN. GOV SIGNS BILL TO PAY BRIDGE COLLAPSE VICTIMS
(Associated Press) - Gov. Tim Pawlenty has approved a $38 million package to compensate victims of the Minneapolis bridge collapse. Read more...
FDA ACTIONS:
DOCTORS TOLD TO CHECK UP ON HEART DEVICE PATIENTS
(Associated Press) - People with implanted heart devices need closer follow-up care, an international panel of heart specialists recommended Wednesday in the first guidelines for monitoring this rapidly growing group of patients. Read more...
CHINA ACCUSES U.S. OF SHODDY PROBE INTO TAINTED HEPARIN
(Associated Press) - China's drug safety agency accused the United States on Tuesday of blocking Beijing's inquiry into a blood thinner linked to 81 deaths by refusing to provide details on victims and specifics about drug production. Read more...
Related Resources
• Defective and Dangerous Products
RECENT CASE SUMMARIES:
NORTH TEXAS SPECIALTY PHYSICIANS V. FTC
(U.S. 5th Cir., May 14, 2008) - Petition for review of an opinion and order by the FTC regarding allegations of price fixing is granted and the case remanded to modify the order where: 1) the FTC had jurisdiction by virtue of the adverse effects to out-of-state parties; 2) although defendant is a single entity, it is controlled by a group of competitors with substantially similar economic interests; 3) a quick-look analysis was appropriate since the anticompetitive effects were obvious; 4) denial of a discovery motion did not violate due process; and 5) a subsection of the remedial order was overly broad and internally inconsistent. Read more...
ACUMED, LLC V. STRYKER CORP.
(U.S. Fed. Cir., May 13, 2008) - In a patent case involving a product used to treat proximal humeral bone fractures, dismissal of the action based on claim preclusion is reversed and remanded where defendant conceded that the accused devices were not essentially the same, and thus it failed to meet its burden to show that the infringement claim in the prior action was the same as the infringement claim in the present action. Read more...
B & H MED., L.L.C. V. ABP ADMIN., INC.
(U.S. 6th Cir., May 7, 2008) - In an antitrust case involving the legality of an agreement which established an exclusive network of preferred providers to supply types of medical equipment to enrollees in certain health-benefits plans offered to Chrysler, Ford, and state employees and retirees, a judgment and sanctions against plaintiff whose application to the network was rejected are affirmed, and appellate sanctions imposed, where: 1) plaintiff's antitrust claims lacked any conceivable merit; 2) a challenge to a discovery order failed; and 3) sanctions imposed below were not an abuse of discretion, and further, appellate sanctions were warranted. Read more...
Back to newsletter list
